• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Radionuclide hepatic perfusion index and ultrasonography: assessment of portal hypertension in clinical practice.

作者信息

Seidlová V, Hobza J, Pumprla J, Charouzek J

出版信息

Acta Univ Palacki Olomuc Fac Med. 1989;122:213-21.

PMID:2530818
Abstract

The final value of portal blood flow pressure depends on the degree of vascular obstruction, then on the resistance in collateral vessels and, last, on splanchnic blood flow. The iniciating cause of portal hypertension most often lies in advancing anatomical damage leading to increased resistance and, consequently, to a reduction of portal blood flow, and simultaneous reciprocal development of extrahepatic collaterals. The determination of a true portal flow is a necessity particularly when deciding about a shunt surgery and its type, but it also supplies valuable information on the degree of portal flow restriction and, in this way, on the progress of pathophysiological changes, their extent and advance. The technique of radionuclide angiography and determination of the hepatic perfusion index (HPI) proposed by Sarper appears to be a profitable noninvasive method supplying well reproducible information on portal blood flow. Sarper proved it to be correlated with the degree of portal hypertension established by angiography. Ultrasonographic criteria of portal hypertension include dilatation of the portal vein in the region of the hilus hepatis exceeding 15 mm, and a more than 10 mm dilatation of the splenic vein above the spine. The mean HPI value obtained from the examination of 19 subjects without liver involvement was 0.6956 +/- 0.0583. The group of chronic hepatopathies included 19 patients with bioptically verified chronic hepatitis without reconstruction and/or steatosis, and 32 patients with liver cirrhosis likewise confirmed by biopsy: portosystemic shunts could be demonstrated in 14 of the latter. (ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

1
Radionuclide hepatic perfusion index and ultrasonography: assessment of portal hypertension in clinical practice.
Acta Univ Palacki Olomuc Fac Med. 1989;122:213-21.
2
[Regional liver circulation and scintigraphic imaging of portal circulation with 133Xe].[区域肝循环与用¹³³氙进行门静脉循环的闪烁成像]
Acta Med Austriaca Suppl. 1984;31:1-28.
3
[Regional liver circulation and the scintigraphic representation of the portal circulation with 133Xe].[局部肝循环与用¹³³氙对门静脉循环的闪烁显像]
Acta Med Austriaca. 1984;11(3-4):1-28.
4
Angioscintigraphic assessment of arterial and portal liver blood flow: comparison with splanchnic angiography.
Nuklearmedizin. 1987 Apr;26(2):83-6.
5
[Radionuclide and ultrasound studies in liver cirrhosis with portal hypertension].[放射性核素及超声检查在肝硬化门静脉高压症中的应用]
Med Radiol (Mosk). 1988 Aug;33(8):42-7.
6
Estimation of the relative liver perfusion using two methods of radionuclide angiography in the patients with hemodynamic disorders in the portal system.
Acta Chir Iugosl. 2008;55(1):11-6. doi: 10.2298/aci0801011a.
7
Portal hypertension: a review of portosystemic collateral pathways and endovascular interventions.门静脉高压症:门体侧支循环途径及血管内介入治疗综述
Clin Radiol. 2015 Oct;70(10):1047-59. doi: 10.1016/j.crad.2015.06.077. Epub 2015 Jul 15.
8
Ultrasonographic study of portal venous system in portal hypertension and after portosystemic shunt operations.门静脉高压症及门体分流术后门静脉系统的超声检查研究
Surgery. 1984 Mar;95(3):261-9.
9
Hepatic perfusion index in portal hypertension of cirrhotic and non-cirrhotic aetiologies.肝硬化和非肝硬化病因所致门静脉高压症中的肝脏灌注指数
Nucl Med Commun. 1996 Jun;17(6):520-2. doi: 10.1097/00006231-199606000-00011.
10
[Usefulness of ultrasonography in the diagnosis of portal hypertension].[超声检查在门静脉高压诊断中的应用价值]
Rev Esp Enferm Dig. 1998 Nov;90(11):806-12.